A Study to Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 4, 2016

Primary Completion Date

March 27, 2017

Study Completion Date

March 27, 2017

Conditions
Study is Being Conducted in Healthy Volunteers
Interventions
DRUG

Symbicort pMDI with spacer device

Relative bioavailability of budesonide and formoterol delivered via Symbicort pressurized metered-dose inhaler (pMDI) with a spacer device (test)

DRUG

Symbicort pMDI without spacer device

Relative bioavailability of budesonide and formoterol delivered via Symbicort pMDI without a spacer device (reference)

Trial Locations (1)

HA1 3UJ

Research Site, Harrow

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Parexel

INDUSTRY

lead

AstraZeneca

INDUSTRY